• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

Introduction to 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid (CAS No. 2225179-98-4)

2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its versatile applications. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 2225179-98-4, is a key intermediate in the synthesis of various biologically active molecules. Its unique structural features, including the presence of both fluorine and boronic acid functional groups, make it a valuable building block for further chemical modifications and derivatization.

The boronic acid moiety in 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid is particularly noteworthy, as it participates in critical transformations such as Suzuki-Miyaura cross-coupling reactions. These reactions are fundamental in constructing complex organic molecules, including heterocyclic compounds that often exhibit pharmaceutical properties. The fluorine substituents further enhance the compound's reactivity and stability, making it an attractive candidate for drug discovery programs.

In recent years, there has been a surge in research focused on developing novel treatments for various diseases, including cancer and infectious disorders. The demand for high-quality intermediates like 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid has increased accordingly. Researchers have leveraged this compound to synthesize small-molecule inhibitors that target specific biological pathways. For instance, studies have demonstrated its utility in generating pyridine-based scaffolds that interact with enzymes involved in cancer cell proliferation and metabolism.

The incorporation of fluorine atoms into pharmaceutical compounds often enhances their pharmacokinetic properties, such as bioavailability and metabolic stability. This is particularly relevant for 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid, where the electron-withdrawing nature of fluorine influences the electronic distribution of the molecule. Such modifications can lead to improved drug efficacy and reduced side effects, making this compound a promising candidate for further development.

Recent advancements in computational chemistry have also facilitated the design of novel derivatives of 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid. By employing molecular modeling techniques, researchers can predict the binding affinity and selectivity of different analogs against biological targets. This approach has enabled the rapid identification of lead compounds with optimized properties for therapeutic applications.

The synthesis of 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid typically involves multi-step organic transformations, starting from readily available precursors. The process often requires careful optimization to ensure high yields and purity. Given its importance in synthetic chemistry, several synthetic routes have been reported in the literature, each with distinct advantages depending on the desired scale and purity requirements.

One notable application of 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid is in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is associated with numerous diseases, including cancer. By designing molecules that selectively inhibit specific kinases, researchers can develop targeted therapies with improved efficacy and reduced toxicity. The boronic acid component allows for facile coupling with aryl halides or alkynes via cross-coupling reactions, enabling the construction of complex kinase inhibitors.

The agrochemical industry has also benefited from the use of 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid as an intermediate. Fluorinated pyridines are known to exhibit herbicidal and pesticidal properties, making them valuable components in crop protection formulations. Researchers have synthesized various derivatives of this compound to develop environmentally friendly agrochemicals that offer effective pest control while minimizing ecological impact.

In conclusion, 2-Fluoro-6-(2-fluorophenyl)pyridine-3-boronic acid (CAS No. 2225179-98-4) is a multifaceted compound with significant potential in pharmaceutical and agrochemical applications. Its unique structural features enable diverse chemical transformations, making it a valuable tool for drug discovery and crop protection research. As advancements continue to emerge in synthetic chemistry and molecular biology, the role of this compound is expected to expand further, contributing to the development of innovative solutions for global health and agricultural challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)